Literature DB >> 15150266

Mutagenesis of residue betaArg-246 in the phosphate-binding subdomain of catalytic sites of Escherichia coli F1-ATPase.

Zulfiqar Ahmad1, Alan E Senior.   

Abstract

Residues responsible for phosphate binding in F(1)F(0)-ATP synthase catalytic sites are of significant interest because phosphate binding is believed linked to proton gradient-driven subunit rotation. From x-ray structures, a phosphate-binding subdomain is evident in catalytic sites, with conserved betaArg-246 in a suitable position to bind phosphate. Mutations betaR246Q, betaR246K, and betaR246A in Escherichia coli were found to impair oxidative phosphorylation and to reduce ATPase activity of purified F(1) by 100-fold. In contrast to wild type, ATPase of mutants was not inhibited by MgADP-fluoroaluminate or MgADP-fluoroscandium, showing the Arg side chain is required for wild-type transition state formation. Whereas 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl) inhibited wild-type ATPase essentially completely, ATPase in mutants was inhibited maximally by approximately 50%, although reaction still occurred at residue betaTyr-297, proximal to betaArg-246 in the phosphate-binding pocket. Inhibition characteristics supported the conclusion that NBD-Cl reacts in betaE (empty) catalytic sites, as shown previously by x-ray structure analysis. Phosphate protected against NBD-Cl inhibition in wild type but not in mutants. The results show that phosphate can bind in the betaE catalytic site of E. coli F(1) and that betaArg-246 is an important phosphate-binding residue.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15150266     DOI: 10.1074/jbc.M404621200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Dietary bioflavonoids inhibit Escherichia coli ATP synthase in a differential manner.

Authors:  Nagababu Chinnam; Prasanna K Dadi; Shahbaaz A Sabri; Mubeen Ahmad; M Anaul Kabir; Zulfiqar Ahmad
Journal:  Int J Biol Macromol       Date:  2010-03-25       Impact factor: 6.953

Review 2.  Medicinal chemistry of ATP synthase: a potential drug target of dietary polyphenols and amphibian antimicrobial peptides.

Authors:  Zulfiqar Ahmad; Thomas F Laughlin
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

3.  Effect of structural modulation of polyphenolic compounds on the inhibition of Escherichia coli ATP synthase.

Authors:  Zulfiqar Ahmad; Mubeen Ahmad; Florence Okafor; Jeanette Jones; Abdelmajeed Abunameh; Rakesh P Cheniya; Ismail O Kady
Journal:  Int J Biol Macromol       Date:  2012-01-20       Impact factor: 6.953

Review 4.  ATP synthase and the actions of inhibitors utilized to study its roles in human health, disease, and other scientific areas.

Authors:  Sangjin Hong; Peter L Pedersen
Journal:  Microbiol Mol Biol Rev       Date:  2008-12       Impact factor: 11.056

Review 5.  Two ATPases.

Authors:  Alan E Senior
Journal:  J Biol Chem       Date:  2012-07-20       Impact factor: 5.157

Review 6.  ATP synthase: a molecular therapeutic drug target for antimicrobial and antitumor peptides.

Authors:  Zulfiqar Ahmad; Florence Okafor; Sofiya Azim; Thomas F Laughlin
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

7.  Futile cycling increases sensitivity toward oxidative stress in Escherichia coli.

Authors:  Kristin J Adolfsen; Mark P Brynildsen
Journal:  Metab Eng       Date:  2015-02-27       Impact factor: 9.783

8.  A functionally important hydrogen-bonding network at the betaDP/alphaDP interface of ATP synthase.

Authors:  Hui Z Mao; Christopher G Abraham; Arathianand M Krishnakumar; Joachim Weber
Journal:  J Biol Chem       Date:  2008-06-25       Impact factor: 5.157

9.  Functional importance of αIle-346 and αIle-348 in the catalytic sites of Escherichia coli ATP synthase.

Authors:  Chao Zhao; Hiba Syed; Sherif S Hassan; Vineet K Singh; Zulfiqar Ahmad
Journal:  Arch Biochem Biophys       Date:  2016-01-14       Impact factor: 4.013

10.  Studies of nucleotide binding to the catalytic sites of Escherichia coli betaY331W-F1-ATPase using fluorescence quenching.

Authors:  Vladimir V Bulygin; Yakov M Milgrom
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.